Business Development

Successful partnerships are an integral part of our business strategy. Lorus is always looking for opportunities to leverage its rich pool of research and later stage novel anti-cancer agents. Our central focus is to discover and develop multiple lead products, which we intend to advance through to Phase II clinical trials. Upon successful completion of Phase II trials, we decide whether to finance further clinical development by ourselves or enter into strategic partnerships whereby third parties will finance further clinical development. If Lorus finances further clinical development, upon demonstration of clinical benefit in a Phase III clinical trial and receipt of approval to market a product, the Company would likely seek third parties as partners to market, sell and distribute such products.

Lorus’ Business Development Team actively seeks innovative products and technologies for development and commercialization, either on our own or in cooperation with partners, as part of a near and long term renewal strategy. We utilize strategic alliances to give us access to cutting-edge science and innovative paths to market our products. We consider and evaluate regional and global partnership opportunities that enhance the value of our programs through a combination of technologies, large-scale clinical trial management expertise, financial commitment, and commercial capabilities.

Out-Licensing/Partnering

The overall goal of our licensing strategy is to develop a number of strategic relationships for the development of our products and technologies. Given our extensive technology portfolio, we intend to pursue structures such as out-licensing specific or exclusive uses of our technologies and joint collaboration development agreements. Our goal is to ensure that all of our technology platforms are under active development through the use of licensing and/or joint collaborations.

In addition to Lorus’ core programs, we are also open to discussing collaboration opportunities with partners who bring complementary expertise and experience such that we can utilize our technology in non-oncology areas or other areas of unmet medical needs.

A brief non-confidential summary of each program is listed below for review.

In-Licensing

Lorus is always interested in collaboration opportunities with corporate and academic partners whenever there is strong scientific merit and a strategic fit. As part of our corporate business development activities, Lorus has established an aggressive in-licensing strategy and is actively seeking high quality development candidates that meet defined criteria to extend and complement our existing pipeline of novel anticancer therapeutics.

We are actively seeking to in-license novel and promising drug candidates that address unmet medical needs in oncology, typically ranging from advanced preclinical up to Phase II clinical development. We will look at all types of business arrangements as long as these opportunities meet our stringent screening process based on sound scientific, medical and economic metrics.

Business Development Contact

For any business development enquiries, or if you wish to present an in-licensing opportunity, please contact our Business Development Department:

Saeid Babaei, PhD, MBA
VP, Business Development
Telephone +1.416.798.1200 x490
Fax: +1.416.798.2200
Email: sbabaei@lorusthera.com